APA

van Waterschoot R. A. B., Lagas J. S., Wagenaar E., van der Kruijssen C. M. M., van Herwaarden A. E., Song J., Rooswinkel R. W., van Tellingen O., Rosing H., Beijnen J. H. & Schinkel A. H. (20091221). Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. : Cancer research.

Chicago

van Waterschoot Robert A B, Lagas Jurjen S, Wagenaar Els, van der Kruijssen Cornelia M M, van Herwaarden Antonius E, Song Ji-Ying, Rooswinkel Rogier W, van Tellingen Olaf, Rosing Hilde, Beijnen Jos H and Schinkel Alfred H. 20091221. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. : Cancer research.

Harvard

van Waterschoot R. A. B., Lagas J. S., Wagenaar E., van der Kruijssen C. M. M., van Herwaarden A. E., Song J., Rooswinkel R. W., van Tellingen O., Rosing H., Beijnen J. H. and Schinkel A. H. (20091221). Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. : Cancer research.

MLA

van Waterschoot Robert A B, Lagas Jurjen S, Wagenaar Els, van der Kruijssen Cornelia M M, van Herwaarden Antonius E, Song Ji-Ying, Rooswinkel Rogier W, van Tellingen Olaf, Rosing Hilde, Beijnen Jos H and Schinkel Alfred H. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. : Cancer research. 20091221.